DuoDERM® CGF® Border Dressing
DuoDERM® CGF® Border Dressing can be used for "hard-to-dress" areas. Features a wide outer border that does not require additional taping.
• Promotes granulation and facilitates autolytic debridement
• Can be easily and gently molded into place
• Can be worn for up to seven days
DuoDERM® CGF® Border Dressing in indicated for use on: dermal ulcers, including full-thickness wounds, pressure ulcer management (stages 1-4), leg ulcer management, superficial wounds (e.g., minor abrasions), second-degree burns and donor sites
Contraindicated for use on individuals with a known sensitivity to the dressing or its components.
DuoDERM® CGF® Border Dressings are not recommended for use on third-degree burns.
When used on dermal ulcers:
- Initial use of this product should be under the direction of a health professional.
- DuoDERM® CGF® Border Dressings only provide local management of the wound site. In pressure injury care, other aspects such as repositioning of the patient and nutritional support should not be neglected. In leg ulcer care, lack of adequate rest in patients with vascular (arterial or venous) insufficiency can increase the amount of local edema and hinder potential healing.
- Increased Wound Size: Deeper tissue damage may have already occurred under an apparent superficial dermal ulcer. When using any occlusive dressing in the presence of necrotic material, the wound may increase in size and depth during the initial phase of management as the necrotic debris is cleaned away. Leg ulcers resulting from vasculitis may rapidly deteriorate during exacerbation of the underlying disorder.
Odor: Wounds, particularly those that are large or necrotic, are often accompanied by a disagreeable odor; however, this is not necessarily indicative of infection. The odor should disappear when the wound is cleansed (see infection).
Infection: If signs of clinical infection should develop, such as: uncharacteristic odor or change in the color of the exudate, fever or cellulitis (tenderness and erythema in the area of the wound), a bacterial culture of the wound site should be taken. If clinical signs of infection are present, appropriate medical treatment should be initiated. DuoDERM® dressings may be continued during the treatment at the discretion of the clinician.
Granulation: Excessive granulation tissue may develop in some wounds when using occlusive dressings.
|Antimicrobial format available|
|Conforms readily to wound||●|
|Gels on contact w/ exudate||●|
|Impermeable to outside contaminants||●|
|Variety of sizes||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
DuoDERM® CGF® Border Dressings are sterile and should be handled appropriately. Choose a dressing that allows the DuoDERM® CGF® Border Dressing mass to extend beyond the wound margin by at least 1(1/4)", covering all unhealthy tissue. Cleanse the wound according to hospital practice. Irrigate with saline and dry the surrounding skin to ensure it is free of any greasy substance. Use of the dressings helps facilitate the liquefaction and removal of dead tissue; however, eschar that is particularly thick or fused to the wound margins should be removed prior to application of the dressing.
Press down on the skin and carefully lift an edge of the dressing. Continue around until all edges are free. Repeat cleansing procedure. It is unnecessary to remove all residual dressing material from the surrounding skin. Leave the dressing in place (not more than seven days) unless it is uncomfortable, leaking or there are clinical signs of infection.
DuoDERM® Paste or DuoDERM® Hydroactive® Granules may be used with this dressing. See the instructions for use with each product.